114 related articles for article (PubMed ID: 28802570)
1. Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study.
Wolff I; Scavuzzo A; Capitanio U; Klatte T; Shariat SF; Wagener N; Zastrow S; Borgmann H; Krabbe LM; Hutterer G; May M; Brookman-May SD;
Urology; 2017 Nov; 109():107-114. PubMed ID: 28802570
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients.
Borgmann H; Musquera M; Haferkamp A; Vilaseca A; Klatte T; Shariat SF; Scavuzzo A; Jimenez Rios MA; Wolff I; Capitanio U; Dell'Oglio P; Krabbe LM; Herrmann E; Ecke T; Vergho D; Huck N; Wagener N; Pahernik S; Zastrow S; Wirth M; Surcel C; Mirvald C; Prochazkova K; Hutterer G; Zigeuner R; Cindolo L; Hora M; Stief CG; May M; Brookman-May SD
World J Urol; 2017 Dec; 35(12):1891-1897. PubMed ID: 28836063
[TBL] [Abstract][Full Text] [Related]
3. Exploratory Subgroup Analyses of Renal Function and Overall Survival in European Organization for Research and Treatment of Cancer randomized trial of Nephron-sparing Surgery Versus Radical Nephrectomy.
Scosyrev E; Messing EM; Sylvester R; Van Poppel H
Eur Urol Focus; 2017 Dec; 3(6):599-605. PubMed ID: 28753863
[TBL] [Abstract][Full Text] [Related]
4. Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma.
Milonas D; Skulčius G; Baltrimavičius R; Auškalnis S; Kinčius M; Matjošaitis A; Gudinavičienė I; Smailytė G; Jievaltas M
Medicina (Kaunas); 2013; 49(5):223-8. PubMed ID: 24247918
[TBL] [Abstract][Full Text] [Related]
5. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project).
May M; Surcel C; Capitanio U; Dell'Oglio P; Klatte T; Shariat S; Ecke T; Wolff I; Vergho D; Wagener N; Huck N; Pahernik S; Zastrow S; Wirth M; Borgmann H; Haferkamp A; Musquera M; Krabbe LM; Herrmann E; Scavuzzo A; Mirvald C; Hutterer G; Zigeuner R; Stief CG; Waidelich R; Cindolo L; Kalusova K; Brookman-May SD;
Scand J Urol; 2017 Aug; 51(4):269-276. PubMed ID: 28399699
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes in patients with large (≥7cm) clear cell renal cell carcinomas treated with nephron-sparing surgery versus radical nephrectomy: Results of a multicenter cohort with long-term follow-up.
Janssen MWW; Linxweiler J; Terwey S; Rugge S; Ohlmann CH; Becker F; Thomas C; Neisius A; Thüroff JW; Siemer S; Stöckle M; Roos FC
PLoS One; 2018; 13(5):e0196427. PubMed ID: 29723225
[TBL] [Abstract][Full Text] [Related]
8. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
9. Nephron Sparing Surgery Has Better Oncologic Outcomes Than Extirpative Nephrectomy in T1a but Not in T1b or T2 Stage Renal Cell Carcinoma.
Luo Y; Chen SS; Bai L; Luo L; Zheng XG; Wang S
Med Sci Monit; 2017 Jul; 23():3480-3488. PubMed ID: 28717119
[TBL] [Abstract][Full Text] [Related]
10. Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma.
Larcher A; Capitanio U; Terrone C; Volpe A; De Angelis P; Dehó F; Fossati N; Dell'Oglio P; Antonelli A; Furlan M; Simeone C; Serni S; Carini M; Minervini A; Fiori C; Porpiglia F; Briganti A; Montorsi F; Bertini R
J Urol; 2016 Oct; 196(4):1008-13. PubMed ID: 27235789
[TBL] [Abstract][Full Text] [Related]
11. A snapshot of nephron-sparing surgery in Italy: a prospective, multicenter report on clinical and perioperative outcomes (the RECORd 1 project).
Schiavina R; Mari A; Antonelli A; Bertolo R; Bianchi G; Borghesi M; Brunocilla E; Fiori C; Longo N; Martorana G; Mirone V; Morgia G; Novara G; Porpiglia F; Rovereto B; Serni S; Simeone C; Sodano M; Terrone C; Carini M; Minervini A
Eur J Surg Oncol; 2015 Mar; 41(3):346-52. PubMed ID: 25583459
[TBL] [Abstract][Full Text] [Related]
12. Age distribution for partial and radical nephrectomy: whose nephrons are being spared?
von Klot C; Herrmann TR; Wegener G; Kuczyk MA; Hupe MC; Akkoyun M; Peters I; Kramer MW; Merseburger AS
Adv Ther; 2013 Oct; 30(10):924-32. PubMed ID: 24155056
[TBL] [Abstract][Full Text] [Related]
13. A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor.
Cost NG; Sawicz-Birkowska K; Kajbafzadeh AM; Tourchi A; Parigi GB; Guillén G; DeFoor WR; Apoznanski W
Urology; 2014 Jun; 83(6):1388-93. PubMed ID: 24768019
[TBL] [Abstract][Full Text] [Related]
14. Surveillance Following Nephron-Sparing Surgery: An Assessment of Recurrence Patterns and Surveillance Costs.
Zargar-Shoshtari K; Kim T; Simon R; Lin HY; Yue B; Sharma P; Spiess PE; Poch MA; Pow Sang J; Sexton WJ
Urology; 2015 Aug; 86(2):321-6. PubMed ID: 26187013
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database.
May M; Aziz A; Zigeuner R; Chromecki T; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Hoschke B; Gilfrich C; Feciche B; Stoltze A; Fenske F; Fritsche HM; Figenshau RS; Madison K; Sánchez-Chapado M; Martin Mdel C; Salzano L; Lotrecchiano G; Joniau S; Waidelich R; Stief C; Brookman-May S;
World J Urol; 2013 Oct; 31(5):1073-80. PubMed ID: 23568445
[TBL] [Abstract][Full Text] [Related]
16. The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size.
Pertia A; Managadze L; Chkhotua A
Georgian Med News; 2012 Nov; (212):7-12. PubMed ID: 23221132
[TBL] [Abstract][Full Text] [Related]
17. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
[TBL] [Abstract][Full Text] [Related]
18. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
[TBL] [Abstract][Full Text] [Related]
19. Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life.
May M; Cindolo L; Zigeuner R; De Cobelli O; Rocco B; De Nunzio C; Tubaro A; Coman I; Truss M; Dalpiaz O; Wolff I; Feciche B; Fenske F; Pichler M; Schips L; Figenshau RS; Madison K; Sánchez-Chapado M; Santiago Martin Mdel C; Salzano L; Lotrecchiano G; Waidelich R; Stief C; Sountoulides P; Brookman-May S; ;
Urol Oncol; 2014 Nov; 32(8):1252-8. PubMed ID: 25129141
[TBL] [Abstract][Full Text] [Related]
20. Trends in the surgical management of stage 1 renal cell carcinoma: findings from a population-based study.
White V; Marco DJT; Bolton D; Davis ID; Jefford M; Hill D; Prince HM; Millar JL; Winship IM; Coory M; Giles GG
BJU Int; 2017 Nov; 120 Suppl 3():6-14. PubMed ID: 28452170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
